Respicardia respicardia.com


Public lists: Medical Devices (6162)

Respicardia, formerly Cardiac Concepts, is developing implantable therapies designed to improve respiratory and cardiovascular health. The company's initial product, the remede System, is an implantable stimulation device designed to restore a more regular breathing pattern during sleep for central sleep apnea patients. On April 12th, 2021, Respicardia was acquired by ZOLL Medical Corporation. The terms of the transaction were not disclosed.

Respicardia, formerly Cardiac Concepts, is developing implantable therapies designed to improve respiratory and cardiovascular health. The company's initial product, the remede System, is an implantable stimulation device designed to restore a more r...Show all

Company (Acquired)

Phone: 952-540-4470

Fax:

12400 Whitewater Dr
Suite 150
Minnetonka, 55343
Minnesota, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Respicardia $152.8M Apr 12, 2021
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Respicardia Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Affinity Capital ManagementVenture CapitalMinneapolis, Minnesota, United StatesConvertible Note, Series D, Series C, Series B
Accuitive Medical VenturesVenture CapitalDuluth, Georgia, United StatesConvertible Note, Series D, Series C, Series B
Polaris PartnersVenture CapitalBoston, Massachusetts, United StatesSeries C, Series B
Ares Capital CorporationDebt & Specialty FinanceNew York, New York, United StatesLine of Credit
LivaNovaCorporationLondon, England, United KingdomCorporate Minority
See all 10 investors

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Medical lead and implantation Jul 28, 2017 Nov 03, 2020 Patent
Detecting and treating disordered breathing May 18, 2015 Mar 31, 2020 Patent
Transvascular medical lead Nov 06, 2015 Jan 28, 2020 Patent
System and method to modulate phrenic nerve to prevent sleep apnea Jun 29, 2012 Dec 31, 2019 Patent
Medical lead with preformed bias Oct 03, 2016 Dec 17, 2019 Patent
See all 26 patents